Spire Healthcare Group plc (LON:SPI)
London · Delayed Price · Currency is GBP · Price in GBX 161.80
+2.40 (1.51%)
Apr 16, 2026, 4:42 PM GMT
Spire Healthcare Group Market Cap
Spire Healthcare Group has a market cap or net worth of 648.17 million as of April 16, 2026. Its market cap has decreased by -12.36% in one year.
Market Cap
648.17M
Enterprise Value
1.93B
Revenue
1.58B
Ranking
n/a
PE Ratio
40.45
Stock Price
161.80
Market Cap Chart
Since July 18, 2014, Spire Healthcare Group's market cap has increased from 211.00 to 648.17M, an increase of 307,188,150.24%. That is a compound annual growth rate of 256.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 648.17M | -3.54% |
| Dec 31, 2025 | 671.96M | -26.12% |
| Dec 31, 2024 | 909.51M | -0.63% |
| Dec 29, 2023 | 915.29M | -0.60% |
| Dec 30, 2022 | 920.82M | -8.12% |
| Dec 31, 2021 | 1.00B | 60.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.02B |
| GSK plc | 85.13B |
| Haleon | 31.48B |
| Smith & Nephew | 10.78B |
| Oxford Nanopore Technologies | 1.12B |
| CVS Group | 848.19M |
| Oxford Biomedica | 750.79M |
| Allergy Therapeutics | 677.58M |